澳股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

医药生物股

917.495

-3.651-0.40%

涨家数：10

跌家数：18

平家数：17

市盈率：- -

高：922.116

开：919.676

低：911.838

收：921.146

数据加载中...

Baptista开始对BHP、CSL和Qantas进行分析——AI在其中发挥了重要作用

澳洲财经见闻

美国卫生部长肯尼迪采取最新举措，停止使用含硫柳汞的流感疫苗

Mesoblast(ASX:MSB)首个商业化细胞疗法销售势头喜人股价飙升35%

澳洲财经见闻

“退休金躺赚66万澳元”：揭开澳洲自管养老金最强“印钞机”！

澳洲财经见闻

在投资者乐观的情况下，ASX 200命中率高

澳洲财经见闻

这些澳股即将加入“回购热潮”

澳洲财经见闻

免疫基因向澳洲证交所提交证券报价申请

快讯-澳大利亚Noxopharm启动自体免疫药物试验股价飙升

澳大利亚医疗股因特朗普药品关税细节而暴跌

IMC-IMC.AX 宣布证券发行提案

华尔街洞察

MVF.AX限制性股票托管期满解禁公告

华尔街洞察

IMUGENE LTD将举办Azer-cel新数据线上说明会

华尔街洞察

BUZZ-澳大利亚Imugene因折价配售股价暴跌

华尔街洞察

BIT.AX任命Michael Medway为新董事

华尔街洞察

免疫基因宣布获机构认购2250万美元配股每股定价0.33澳元

华尔街洞察

Imugene宣布以每股0.33澳元价格完成2250万美元配售同步启动1500万澳元购股计划

华尔街洞察

Monash IVF集团任命临时首席财务官，股价应声下挫

华尔街洞察

IMUGENE LTD证券发行提案

华尔街洞察

IMU-IMU.AX宣布拟议发行证券计划

华尔街洞察

Monash IVF集团任命Andrew Maclachlan担任临时首席财务官

华尔街洞察

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK7508/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"医药生物股","latestPrice":917.4949,"timestamp":1753417509928,"preClose":921.1455,"halted":0,"volume":45609744,"delay":0,"changeRate":-0.003963,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-3.650635,"latestTime":"07-25 14:25:10 AEST","open":919.6758,"high":922.11566,"low":911.8384,"amount":204195753,"amplitude":0.011157,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1753423200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1753401600000,1753423200000]],"turnoverRate":0.001673,"increases":11,"decrements":18,"flats":15,"marketCap":141232925475.875,"floatMarketCap":138336888698},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":922.11566,"amplitude":0.011157,"preClose":921.1455,"low":911.8384,"latestPrice":917.4949,"volume":45609744,"delay":0,"open":919.6758,"prevYearClose":936.801,"prevWeekClose":876.9,"prevMonthClose":795.022,"prevQuarterClose":795.022,"fiveDayClose":876.9,"twentyDayClose":779.443,"sixtyDayClose":832.129,"secType":"PLATE","market":"AU","turnoverRate":0.001673,"marketCap":141232925475.875,"floatMarketCap":138336888698,"timestamp":1753417509928,"nameCN":"医药生物股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":10,"down":18,"flat":17},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2554737908","title":"Baptista开始对BHP、CSL和Qantas进行分析——AI在其中发挥了重要作用","url":"https://stock-news.laohu8.com/highlight/detail?id=2554737908","media":"澳洲财经见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554737908?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 10:16","pubTimestamp":1753409795,"startTime":"0","endTime":"0","summary":"本周，Baptista Research的分析师开始对几家ASX上市公司进行覆盖。随后，更多公司也被纳入分析范围，最终这…","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://afndaily.com/baptista%e5%bc%80%e5%a7%8b%e5%af%b9bhp%e3%80%81csl%e5%92%8cqantas%e8%bf%9b%e8%a1%8c%e5%88%86%e6%9e%90-ai%e5%9c%a8%e5%85%b6%e4%b8%ad%e5%8f%91%e6%8c%a5%e4%ba%86%e9%87%8d%e8%a6%81/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHP","BK7511","LU0300736492.USD","BK4168","SGXZ23171101.USD","BK7508","BK7507","LU0300736062.USD","BK4585","BK4086","CSL.AU","LU0728928796.USD","LU1169590202.USD","BK7501","SG9999004303.SGD","QAN.AU","CSL","BK4588","BK7030","BHP.AU","BK7095","LU1169589451.USD","BK7067"],"gpt_icon":0},{"id":"2553424424","title":"美国卫生部长肯尼迪采取最新举措，停止使用含硫柳汞的流感疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2553424424","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553424424?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 01:11","pubTimestamp":1753290693,"startTime":"0","endTime":"0","summary":"更新 2-美国卫生部长肯尼迪采取最新举措，停止使用含硫柳汞的流感疫苗改写第 1 和第 2 段，在第 3 段中增加最新流感季节的数据，在第 4 和第 5 段中增加背景资料路透7月23日 - 美国将停止分发所有含汞防腐剂硫柳汞的流感疫苗，这是美国卫生部长小罗伯特-肯尼迪重塑疫苗政策的最新举措。上个月，由肯尼迪亲自挑选成员组成的疫苗小组投票赞成美国人接种不含硫柳汞的季节性流感疫苗，尽管数十年来的研究表明不存在相关的安全问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250723:nL4S3TK1NN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK7508","BK7067","CSL.AU","BK7501"],"gpt_icon":0},{"id":"2553256068","title":"Mesoblast(ASX:MSB)首个商业化细胞疗法销售势头喜人 股价飙升35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553256068","media":"澳洲财经见闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553256068?lang=zh_cn&edition=fundamental","pubTime":"2025-07-22 21:23","pubTimestamp":1753190621,"startTime":"0","endTime":"0","summary":"Mesoblast Ltd(ASX股票代码:MSB)上周五报告称，其细胞疗法Ryoncil初步销售表现强劲，这是该公司自…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://afndaily.com/mesoblastasxmsb%e9%a6%96%e4%b8%aa%e5%95%86%e4%b8%9a%e5%8c%96%e7%bb%86%e8%83%9e%e7%96%97%e6%b3%95%e9%94%80%e5%94%ae%e5%8a%bf%e5%a4%b4%e5%96%9c%e4%ba%ba-%e8%82%a1%e4%bb%b7%e9%a3%99%e5%8d%8735/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSB","BK7501","BK7067","MSB.AU","BK4006","BK7508"],"gpt_icon":0},{"id":"2552488654","title":"“退休金躺赚66万澳元”：揭开澳洲自管养老金最强“印钞机”！","url":"https://stock-news.laohu8.com/highlight/detail?id=2552488654","media":"澳洲财经见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552488654?lang=zh_cn&edition=fundamental","pubTime":"2025-07-20 09:34","pubTimestamp":1752975264,"startTime":"0","endTime":"0","summary":"在投资选择中，有一条“黄金法则”是：永远不要仅仅因为税收优惠而买入一项资产。 这么做可能会让你陷入高风险、基本面薄弱、费…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://afndaily.com/%e9%80%80%e4%bc%91%e9%87%91%e8%ba%ba%e8%b5%9a66%e4%b8%87%e6%be%b3%e5%85%83%ef%bc%9a%e6%8f%ad%e5%bc%80%e6%be%b3%e6%b4%b2%e8%87%aa%e7%ae%a1%e5%85%bb%e8%80%81%e9%87%91%e6%9c%80%e5%bc%ba/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7511","BK7067","BK7508","CSL.AU"],"gpt_icon":0},{"id":"2552180354","title":"在投资者乐观的情况下，ASX 200命中率高","url":"https://stock-news.laohu8.com/highlight/detail?id=2552180354","media":"澳洲财经见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552180354?lang=zh_cn&edition=fundamental","pubTime":"2025-07-19 08:00","pubTimestamp":1752883205,"startTime":"0","endTime":"0","summary":"出色的全方位表现，因此澳大利亚股票市场每周都有可靠的收益，因为投资者在面对逆境中再次保持看涨。 到周五的市场关闭时，自从…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://afndaily.com/%e5%9c%a8%e6%8a%95%e8%b5%84%e8%80%85%e4%b9%90%e8%a7%82%e7%9a%84%e6%83%85%e5%86%b5%e4%b8%8b%ef%bc%8casx-200%e5%91%bd%e4%b8%ad%e7%8e%87%e9%ab%98/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK7501","BK4118","BK4534","BK7511","CSL.AU","BK7508","UBS","IE0034235071.USD","LU1829250122.USD","BK4588","BK7067"],"gpt_icon":0},{"id":"2552430526","title":"这些澳股即将加入“回购热潮”","url":"https://stock-news.laohu8.com/highlight/detail?id=2552430526","media":"澳洲财经见闻","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552430526?lang=zh_cn&edition=fundamental","pubTime":"2025-07-18 08:39","pubTimestamp":1752799147,"startTime":"0","endTime":"0","summary":"在特朗普回归白宫引发市场不确定性的大背景下，越来越多顶级公司选择回购股票，而不是冒险投资。 CSL、Wesfarmers…","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://afndaily.com/%e8%bf%99%e4%ba%9b%e6%be%b3%e8%82%a1%e5%8d%b3%e5%b0%86%e5%8a%a0%e5%85%a5%e5%9b%9e%e8%b4%ad%e7%83%ad%e6%bd%ae/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","CSL.AU","EPS","BK7511","BK7508","BK7501"],"gpt_icon":0},{"id":"1155449886","title":"免疫基因向澳洲证交所提交证券报价申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1155449886","media":"美股洞察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155449886?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 14:42","pubTimestamp":1752648148,"startTime":"0","endTime":"0","summary":"澳大利亚生物技术企业Imugene Limited于今日正式向澳大利亚证券交易所递交证券报价申请文件。此举标志着该公司资本运作进入新阶段，市场关注其后续流动性变化可能带来的投资机会。根据披露流程，该申请需经交易所合规部门审核。若获批准，IMU普通股将获得持续报价资格，有助于提升二级市场交易活跃度。IMU股价近三个月累计上涨27%，跑赢ASX全普通指数15个百分点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7508","IMU.AU"],"gpt_icon":0},{"id":"1155127986","title":"快讯-澳大利亚Noxopharm启动自体免疫药物试验 股价飙升","url":"https://stock-news.laohu8.com/highlight/detail?id=1155127986","media":"美股洞察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155127986?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 11:46","pubTimestamp":1752637570,"startTime":"0","endTime":"0","summary":"澳大利亚生物科技企业Noxopharm(NOX.AX)股价单日暴涨近46%至0.07澳元，创下去年10月4日以来最大单日涨幅。盘中股价触及6月6日以来最高点，此前该公司宣布自体免疫疾病候选药物SOF-SKN完成首例受试者给药。\n市场交投热度骤增，当日成交量达422,086股，达到30日平均交易量的2.2倍。值得关注的是，尽管今日股价强势反弹，该股年内累计跌幅仍达24.7%。\nSOF-SKN作为治疗自体免疫疾病的创新药物，其临床试验进展引发市场强烈反应。投资者密切关注该药物后续研发进程，这将成为影响企业估值走势的关键变量。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7508","NOX.AU","BK7501"],"gpt_icon":0},{"id":"1110287228","title":"澳大利亚医疗股因特朗普药品关税细节而暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=1110287228","media":"美股洞察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110287228?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 11:42","pubTimestamp":1752637334,"startTime":"0","endTime":"0","summary":"澳大利亚医疗股指数.AXHJ暴跌1.4%，创下自6月23日以来最大日内百分比跌幅。这一剧烈波动源于特朗普总统公布的最新关税计划。他透露，将在7月底前宣布对药品进口征收关税，初期实施低税率，让企业有时间将生产线迁移至美国；随后约一年后，关税将大幅提高至高水平。澳大利亚制药公司严重依赖美国市场销售，此举可能打击其收入来源。行业巨头CSL (CSL.AX) 下跌1.8%，Telix制药 (TLX.AX) 下跌0.7%。年初至今，该子指数已累计下滑5.8%，表现逊于大盘指数.AXJO的4.9%跌幅。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7511","BK7508","BK7501","BK7067","CSL.AU"],"gpt_icon":0},{"id":"1184380937","title":"IMC-IMC.AX 宣布证券发行提案","url":"https://stock-news.laohu8.com/highlight/detail?id=1184380937","media":"华尔街洞察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184380937?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 11:24","pubTimestamp":1752636241,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250716:nASX7BSZg","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","IMC.AU","BK7067"],"gpt_icon":0},{"id":"1104027986","title":"MVF.AX限制性股票托管期满解禁公告","url":"https://stock-news.laohu8.com/highlight/detail?id=1104027986","media":"华尔街洞察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104027986?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 11:23","pubTimestamp":1752636210,"startTime":"0","endTime":"0","summary":"澳大利亚上市公司MVF.AX今日发布限制性股票解禁公告。根据公司披露的监管文件，此前处于托管状态的部分限售股现已满足解禁条件。此次解禁涉及公司根据股权激励计划向特定高管及核心员工授予的股份，解禁后相关持股人将获得完全流通权。市场分析人士指出，限售股解禁可能对二级市场流动性产生短期影响。财务数据显示，MVF.AX近期季度营收保持双位数增长，云服务业务线表现尤为突出。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","MVF.AU","BK7113"],"gpt_icon":0},{"id":"1101643828","title":"IMUGENE LTD将举办Azer-cel新数据线上说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=1101643828","media":"华尔街洞察","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101643828?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 11:11","pubTimestamp":1752635482,"startTime":"0","endTime":"0","summary":"生物技术企业IMUGENE LTD宣布即将召开专题线上会议，重点展示其核心候选疗法Azer-cel的最新临床进展。此次会议将披露该细胞治疗产品在血液肿瘤领域的关键数据集，涵盖治疗响应率、安全特性及作用机制等核心维度。作为靶向CD19的CAR-T疗法，Azer-cel采用创新基因编辑技术以增强抗肿瘤活性。IMUGENE LTD首席执行官强调：\"这些数据标志着我们在实体瘤治疗领域迈出重要一步，为推进后期临床试验奠定了坚实基础。此次数据披露或将影响市场对该企业估值预期的重新评估。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","IMU.AU"],"gpt_icon":0},{"id":"1178224095","title":"BUZZ-澳大利亚Imugene因折价配售股价暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=1178224095","media":"华尔街洞察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178224095?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 10:35","pubTimestamp":1752633338,"startTime":"0","endTime":"0","summary":"Imugene股票今日盘中重挫，一度暴跌18.8%至0.345澳元，创下7月2日以来新低；最终收跌11.8%，报0.375澳元。每股0.33澳元的发行价较7月11日收盘价折价22.4%，突显了市场对折价融资的负面反应。公司还计划通过股票购买计划额外融资1500万澳元，发行价相同。Azer-cel是一种同种异体CAR T细胞疗法，专为治疗复发或难治性弥漫性大B细胞淋巴瘤设计。今日交易量激增至170万股，是30天平均水平的2.9倍。年内迄今，该股已暴跌70.2%，计入今日跌幅。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","IMU.AU","BK7067"],"gpt_icon":0},{"id":"1134036382","title":"BIT.AX任命Michael Medway为新董事","url":"https://stock-news.laohu8.com/highlight/detail?id=1134036382","media":"华尔街洞察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134036382?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 09:57","pubTimestamp":1752631024,"startTime":"0","endTime":"0","summary":"BIT.AX公司宣布，Michael Medway已被正式任命为公司董事。此项决定即刻生效，旨在强化企业治理结构并推动未来发展。作为新任董事，Medway将参与战略决策和监管事务，为公司注入新活力。公告未披露更多细节，但此举被视为优化领导团队的关键一步。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIT.AU","BK7501","BK7067","BK7508"],"gpt_icon":0},{"id":"1121226572","title":"免疫基因宣布获机构认购2250万美元配股 每股定价0.33澳元","url":"https://stock-news.laohu8.com/highlight/detail?id=1121226572","media":"华尔街洞察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121226572?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 09:35","pubTimestamp":1752629732,"startTime":"0","endTime":"0","summary":"澳大利亚生物技术公司免疫基因今日宣布完成两项重要融资安排。根据公告，该公司已获得机构投资者承诺认购价值2250万美元的配售股份，每股定价为0.33澳元。与此同时，公司还启动了股票购买计划，拟以相同每股价格向现有股东募资最高1500万澳元。此次配售定价较该公司最近收盘价折让约12%，融资总额相当于当前市值的近两成。澳交所数据显示，该公司股价过去三个月累计上涨逾40%，反映出市场对其技术平台前景的积极预期。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","IMU.AU","BK7067"],"gpt_icon":0},{"id":"1144997549","title":"Imugene宣布以每股0.33澳元价格完成2250万美元配售 同步启动1500万澳元购股计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1144997549","media":"华尔街洞察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144997549?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 09:26","pubTimestamp":1752629179,"startTime":"0","endTime":"0","summary":"澳大利亚生物制药企业Imugene今日披露重大融资进展。该公司已成功获得总额2250万美元的机构配售确定承诺，配售价格定为每股0.33澳元。此次配售获得市场积极响应，彰显投资者对公司发展前景的信心。在完成配售的同时，Imugene宣布启动上限为1500万澳元的购股计划。作为专注于癌症免疫治疗领域的创新企业，Imugene管线包含多款处于临床阶段的候选药物，此次资金到位将加速其关键项目的试验进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","IMU.AU","BK7508"],"gpt_icon":0},{"id":"1115292914","title":"Monash IVF集团任命临时首席财务官，股价应声下挫","url":"https://stock-news.laohu8.com/highlight/detail?id=1115292914","media":"华尔街洞察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115292914?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 09:21","pubTimestamp":1752628888,"startTime":"0","endTime":"0","summary":"澳大利亚生育医疗服务商Monash IVF集团股价早盘急跌2.4%至0.728澳元，创7月8日以来新低，或录得近两周最大单日跌幅。此次震荡源于公司管理层变动公告——任命安德鲁·麦克拉克伦担任临时首席财务官。现任代理首席执行官贾努丁将继续执掌公司，直至寻获正式CEO人选。值得关注的是，此次人事动荡延续了该公司近期的管理危机。股价持续探底态势反映出投资者对管理层稳定性的强烈质疑。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7113","MVF.AU"],"gpt_icon":0},{"id":"1182081065","title":"IMUGENE LTD证券发行提案","url":"https://stock-news.laohu8.com/highlight/detail?id=1182081065","media":"华尔街洞察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182081065?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 09:05","pubTimestamp":1752627944,"startTime":"0","endTime":"0","summary":"IMUGENE LTD近日宣布一项证券发行计划，旨在通过发行新证券筹集资金。该提案涉及公司战略发展，目标是为未来增长项目注入资本，增强市场竞争力。公司强调，此举将优化财务结构，并为投资者提供更多机会。发行细节尚待监管机构批准，预计将根据市场条件推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMU.AU","BK7067","BK7508"],"gpt_icon":0},{"id":"1198493033","title":"IMU-IMU.AX宣布拟议发行证券计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1198493033","media":"华尔街洞察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198493033?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 09:02","pubTimestamp":1752627730,"startTime":"0","endTime":"0","summary":"IMU-IMU.AX公司近日披露了一项证券发行提案。该计划旨在推动企业融资活动，具体条款尚待进一步公告。投资者可关注后续披露以获取详情。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7508","IMU.AU"],"gpt_icon":0},{"id":"1131249329","title":"Monash IVF集团任命Andrew Maclachlan担任临时首席财务官","url":"https://stock-news.laohu8.com/highlight/detail?id=1131249329","media":"华尔街洞察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131249329?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 08:59","pubTimestamp":1752627575,"startTime":"0","endTime":"0","summary":"7月16日——辅助生殖服务提供商Monash IVF集团今日宣布重要人事变动。集团正式任命Andrew Maclachlan担任临时首席财务官一职，此项任命为过渡期安排。与此同时，Malik Jainudeen将继续履行代理首席执行官职责。具有丰富财务管控经验的Maclachlan火线上任，将协助管理层应对当前市场挑战。公司股票代码MVF.AX近期走势平稳，此次人事变动公告或将引发投资者关注。随着辅助生殖行业竞争加剧，Monash IVF集团此次管理团队调整能否带来新气象，将成为后续市场关注焦点。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7113","MVF.AU","BK7508"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":24,"code":"91000000","status":"200"}]}}